Jeremy Grantham's position in Pfizer is currently worth $70 Million. That's 0.22% of their equity portfolio (47th largest holding). The first Pfizer trade was made in Q1 2013. Since then Jeremy Grantham bought shares 21 more times and sold shares on 27 occasions. The investor's estimated purchase price is $83.9 Million, resulting in a loss of 17%.